ClinConnect ClinConnect Logo
Search / Trial NCT00718458

EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)

Launched by DREXEL UNIVERSITY COLLEGE OF MEDICINE · Jul 16, 2008

Trial Information

Current as of June 22, 2025

Completed

Keywords

Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Neurodegenerative Disease Motor Neuron Disease Autonomic Nervous System Neurodegenerative Diseases Movement Disorders

ClinConnect Summary

This study design requires that the individual live in the Philadelphia region. Please contact the Wadsworth Center of the New York State Department of Health and State University of New York at Albany directly if you reside outside of this area.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Medical Subjects:
  • Be able to give consent themselves or via a legally authorized representative.
  • Diagnosed with a neuromuscular disease and have limited ability to communicate.
  • Be able to see visual cues such as targets or letters presented on the screen, and/or ability to hear auditory cues such as tones or words presented through speakers or earphones.
  • Be able to understand and remember instructions concerning participation.
  • Healthy control subjects:
  • Be able to consent to give consent themselves or via a legally authorized representative.
  • Be able to see visual cues such as targets or letters presented on the screen, and/or ability to hear auditory cues such as tones or words presented through speakers or earphones.
  • Be able to understand and remember instructions concerning participation.
  • Exclusion Criteria:
  • Individuals with cognitive impairments that would impact their ability to follow the instructions

About Drexel University College Of Medicine

Drexel University College of Medicine is a prominent academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a sponsor of clinical trials, the College leverages its extensive expertise in medical education and research to explore new therapeutic interventions and improve patient outcomes. Committed to fostering collaboration among multidisciplinary teams, Drexel University College of Medicine prioritizes ethical standards and regulatory compliance in its research endeavors, ensuring the safety and well-being of trial participants while contributing valuable insights to the medical community.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Terry Heiman-Patterson, MD

Principal Investigator

MDA/ALS Center of Hope

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials